217 related articles for article (PubMed ID: 16573803)
1. Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn's disease and ulcerative colitis.
Gilman J; Shanahan F; Cashman KD
Aliment Pharmacol Ther; 2006 Apr; 23(7):1007-16. PubMed ID: 16573803
[TBL] [Abstract][Full Text] [Related]
2. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
3. Seasonality of vitamin D status and bone turnover in patients with Crohn's disease.
McCarthy D; Duggan P; O'Brien M; Kiely M; McCarthy J; Shanahan F; Cashman KD
Aliment Pharmacol Ther; 2005 May; 21(9):1073-83. PubMed ID: 15854168
[TBL] [Abstract][Full Text] [Related]
4. Vitamin K status in patients with Crohn's disease and relationship to bone turnover.
Duggan P; O'Brien M; Kiely M; McCarthy J; Shanahan F; Cashman KD
Am J Gastroenterol; 2004 Nov; 99(11):2178-85. PubMed ID: 15555000
[TBL] [Abstract][Full Text] [Related]
5. An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
Sugimoto K; Ikeya K; Iida T; Kawasaki S; Arai O; Umehara K; Watanabe F; Tani S; Oishi S; Osawa S; Yamamoto T; Hanai H
Dig Dis Sci; 2016 Jan; 61(1):99-106. PubMed ID: 26254083
[TBL] [Abstract][Full Text] [Related]
6. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
[TBL] [Abstract][Full Text] [Related]
7. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
Dresner-Pollak R; Karmeli F; Eliakim R; Ackerman Z; Rachmilewitz D
Am J Gastroenterol; 2000 Mar; 95(3):699-704. PubMed ID: 10710060
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis).
Scharla SH; Minne HW; Lempert UG; Leidig G; Hauber M; Raedsch R; Ziegler R
Exp Clin Endocrinol; 1994; 102(1):44-9. PubMed ID: 8005208
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
[TBL] [Abstract][Full Text] [Related]
10. Increased serum bone sialoprotein concentrations in patients with Crohn's disease.
Faust D; Menge F; Armbruster FP; Lembcke B; Stein J
Z Gastroenterol; 2003 Mar; 41(3):243-7. PubMed ID: 12664344
[TBL] [Abstract][Full Text] [Related]
11. Association of vitamin K deficiency with bone metabolism and clinical disease activity in inflammatory bowel disease.
Nakajima S; Iijima H; Egawa S; Shinzaki S; Kondo J; Inoue T; Hayashi Y; Ying J; Mukai A; Akasaka T; Nishida T; Kanto T; Tsujii M; Hayashi N
Nutrition; 2011 Oct; 27(10):1023-8. PubMed ID: 21482072
[TBL] [Abstract][Full Text] [Related]
12. Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease.
Silvennoinen J
J Intern Med; 1996 Feb; 239(2):131-7. PubMed ID: 8568480
[TBL] [Abstract][Full Text] [Related]
13. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
[TBL] [Abstract][Full Text] [Related]
14. Metabolic bone assessment in patients with inflammatory bowel disease.
Abitbol V; Roux C; Chaussade S; Guillemant S; Kolta S; Dougados M; Couturier D; Amor B
Gastroenterology; 1995 Feb; 108(2):417-22. PubMed ID: 7835582
[TBL] [Abstract][Full Text] [Related]
15. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.
Abreu MT; Kantorovich V; Vasiliauskas EA; Gruntmanis U; Matuk R; Daigle K; Chen S; Zehnder D; Lin YC; Yang H; Hewison M; Adams JS
Gut; 2004 Aug; 53(8):1129-36. PubMed ID: 15247180
[TBL] [Abstract][Full Text] [Related]
16. Seasonal variability of vitamin D status in patients with inflammatory bowel disease - A retrospective cohort study.
Janssen CE; Globig AM; Busse Grawitz A; Bettinger D; Hasselblatt P
PLoS One; 2019; 14(5):e0217238. PubMed ID: 31120977
[TBL] [Abstract][Full Text] [Related]
17. Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease.
Lamb EJ; Wong T; Smith DJ; Simpson DE; Coakley AJ; Moniz C; Muller AF
Aliment Pharmacol Ther; 2002 Nov; 16(11):1895-902. PubMed ID: 12390098
[TBL] [Abstract][Full Text] [Related]
18. Increased degradation of type I collagen in patients with inflammatory bowel disease.
Silvennoinen J; Risteli L; Karttunen T; Risteli J
Gut; 1996 Feb; 38(2):223-8. PubMed ID: 8801201
[TBL] [Abstract][Full Text] [Related]
19. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
Bernstein CN; Seeger LL; Sayre JW; Anton PA; Artinian L; Shanahan F
J Bone Miner Res; 1995 Feb; 10(2):250-6. PubMed ID: 7754804
[TBL] [Abstract][Full Text] [Related]
20. Alterations in bone metabolism in children with inflammatory bowel disease: an in vitro study.
Hyams JS; Wyzga N; Kreutzer DL; Justinich CJ; Gronowicz GA
J Pediatr Gastroenterol Nutr; 1997 Mar; 24(3):289-95. PubMed ID: 9138175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
